Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11787854 Immunological targeting of pathological tau proteins

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

November 5, 2020

Date of Patent

October 17, 2023

Patent Application Number

17090359

Patent Citations

US Patent 7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits

US Patent 8012936 Tau fragments for immunotherapy

US Patent 7408027 Tools for the diagnosis and treatment of Alzheimer's disease

US Patent 7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits

US Patent 7446180 Conformationally abnormal forms of tau proteins and specific antibodies thereto

US Patent 7479482 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid β, prion protein, amylin, α-synuclein, or polyglutamine repeats for induction of an immune response thereto

US Patent 7632816 Treatment of Alzheimer amyloid deposition

Patent Inventor Names

Einar M. Sigurdsson

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 11787854 Immunological targeting of pathological tau proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.